Understanding Crohn’s Disease

December 2014
Australian Nursing & Midwifery Journal;Dec2014/Jan2015, Vol. 22 Issue 6, p24
The article presents an excerpt from the "Understanding Crohn's Disease" course which is available on the Body Systems Training Room of the Australian Nursing and Midwifery Federation and can be used by nurses and midwives to gain continuing professional development credits.


Related Articles

  • Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies. Icht, Oded; Yanai, Henit; Ron, Yulia; Rosner, Guy; Yaron, ayala; Waizbard, amir; Ziv-Baran, Tomer; Fishman, Sigal; Dotan, Iris // Digestion;Oct2017, Vol. 96 Issue 3, p135 

    Background: There has been a paradigm shift in the treatment of Crohn's disease (CD) involving the rapid introduction of biologics and/or immunomodulators after diagnosis. We wished to assess whether this was applied to patients with newly diagnosed CD in a tertiary inflammatory bowel disease...

  • Diagnosis and Management of Crohn's Disease. WILKINS, THAD; JARVIS, KATHRYN; PATEL, JIGNESHKUMAR // American Family Physician;12/15/2011, Vol. 84 Issue 12, preceding p1366 

    Crohn's disease is a chronic inflammatory condition affecting the gastrointestinal tract at any point from the mouth to the rectum. Patients may experience diarrhea, abdominal pain, fever, weight loss, abdominal masses, and anemia. Extraintestinal manifestations of Crohn's disease include...

  • Management of Active Crohn Disease. Cheifetz, Adam S. // JAMA: Journal of the American Medical Association;5/22/2013, Vol. 309 Issue 20, p2150 

    The article focuses on a research whose objective was to review the diagnosis and management of moderate to severe Crohn disease along with a focus on newer treatments and goals of care. As mentioned, the research concluded that although mesalamines are still often used to treat Crohn disease,...

  • Successful Azathioprine Treatment with Metabolite Monitoring in a Pediatric Inflammatory Bowel Disease Patient Homozygous for TPMT*3C. Mi-Na Lee; Hye In Woo; Yoo Min Lee; Ben Kang; Jong-Won Kim; Yon Ho Choe; Soo-Youn Lee // Yonsei Medical Journal;Nov2013, Vol. 54 Issue 6, p1545 

    Thiopurine S-methyltransferase (TPMT) methylates purine analogues, showing TPMT activity in inverse relation to concentrations of active metabolites such as 6-thioguanine nucleotide (6-TGN). With conventional dosing of thiopurines, patients with homozygous variant TPMT alleles consistently...

  • Editorial: What to Take From TREAT? Hanauer, Stephen B // American Journal of Gastroenterology;Sep2012, Vol. 107 Issue 9, p1423 

    The TREAT Registry is an updated submission of the 5-year follow-up of Crohn's disease patients from community and academic centers in North America treated with or without infliximab. Over 6,000 patients were followed for risks of mortality and serious infections. Similar to data presented...

  • Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectives. Campbell, James P.; Vaughn, Byron P. // Clinical & Experimental Gastroenterology;Aug2016, Vol. 9, p237 

    Despite improvements in medical therapies for Crohn's disease (CD), up to 70% of patients require surgery within 10 years of diagnosis. Surgery is not curative, and almost all patients will experience endoscopic recurrence, and many will go on to clinical recurrence. Identifying patients at...

  • Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study. Portela, Francisco; Lago, Paula; Cotter, José; Gonçalves, Raquel; Vasconcelos, Helena; Ministro, Paula; Lopes, Susana; Eusébio, Marta; Morna, Henrique; Cravo, Marilia; Peixe, Paula; Cremmers, Isabel; Sousa, Helena; Deus, João; Duarte, Maria; Magro, Fernando // Digestion;Jun2016, Vol. 93 Issue 3, p214 

    Background: Anaemia is the most common complication in patients with inflammatory bowel disease (IBD). This study aims to assess the prevalence of anaemia in IBD patients and to know its characteristics with regard to the main IBD clinical features. Methods: An observational cross-sectional...

  • Guidelines for the management of inflammatory bowel disease in adults. Craig Mowat // Gut;May2011, Vol. 60 Issue 5, p571 

    The management of inflammatory bowel disease represents a key component of clinical practice for members of the British Society of Gastroenterology (BSG). There has been considerable progress in management strategies affecting all aspects of clinical care since the publication of previous BSG...

  • Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model. Qing-Kang Lv; Ju-Xiong Liu; Su-Nan Li; Ying-Jie Gao; Yan Lv; Zi-Peng Xu; Bing-Xu Huang; Shi-Yao Xu; Dong-Xue Yang; Ya-Long Zeng; Dian-Feng Liu; Wei Wang // International Journal of Molecular Sciences;Nov2015, Vol. 16 Issue 11, p26654 

    Mycophenolate mofetil (MMF) is an alternative immunosuppressive agent that has been reported to be effective and well tolerated for the treatment of refractory inflammatory bowel disease (IBD). The aim of this study was to investigate the therapeutic effect of MMF on intestinal injury and tissue...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics